EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

A randomized controlled trial of a multimodality digital health intervention to aid the delivery of the modified ketogenic diet therapy for epilepsy: The Keto eCoach trial protocol

Neha Kaul iD, Lucy Vivash iD, Susanna Chen iD, Lillian King iD, Hannah Johns, Leonid Churilov iD, Zhibin Chen iD, John-Paul Nicolo iD, Danielle Heaven, Ella Meredith, Ryan Ervine, Lisa Todd und 7 weitere

Epilepsia Open · 2026

DOI: 10.1002/epi4.70345 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Epilepsia Open, 2026. Verfasst von Neha Kaul und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Diet, Ketogenic, Drug Resistant Epilepsy. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Dietary therapy is an effective treatment for drug‐resistant epilepsy; however, low adherence presents a significant barrier to use in the clinical setting. This study aims to evaluate a multimodality digital health intervention to overcome this barrier and improve outcomes in adults undertaking the modified ketogenic diet for epilepsy.

Method

This is a two‐arm, randomized, controlled trial. A total of 136 participants will be randomized 1:1 to receive the modified ketogenic diet as per standard clinical care, or with the addition of the multimodality digital health intervention for 12 weeks. The intervention will include three components: (1) digital diaries, (2) a novel, at‐home, saliva‐based ketone testing device, and (3) dynamic dietitian support.

Results

The primary treatment benefit will be determined using the epilepsy desirability of outcome rank, a composite outcome measure co‐designed with people living with drug‐resistant epilepsy. Secondary outcomes will include seizure frequency, treatment retention, adverse events, psychiatric symptoms, quality of life, medication use, cost effectiveness, and acceptability of the intervention. Significance The results of this trial will provide evidence on the effectiveness of using this innovative digital health intervention approach to improve treatment outcomes of dietary therapy for drug‐resistant epilepsy. Ethics and Dissemination This study has received approval from the Alfred Hospital Human Research Ethics Committee (Reference No.: 723/23). The results will be disseminated via peer‐reviewed publications and publicly available plain language summaries. Trial Registration Number Australian New Zealand Clinical Trials Registry (ANZCTR, ACTRN12624000486527). Plain Language Summary This trial aims to find out if a 12‐week digital health program can improve treatment outcomes of people living with epilepsy. We will invite 136 people commencing on the modified ketogenic diet to be randomly assigned to the digital health program or standard clinic care. The treatment outcome will be assessed combining seizure frequency, side effects, and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, KetogenicDrug Resistant EpilepsyAdultHumansDigital HealthQuality of LifeRandomized Controlled Trials as TopicTreatment Outcome

Stichwörter der Autor:innen

dietary therapydigital healthdrug‐resistant epilepsyketogenic diet

Autor:innen und Institutionen

  • Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
  • Department of Nutrition and Dietetics, Alfred Heath, Melbourne, Victoria, Australia.
  • Department of Neurology, Alfred Health, Melbourne, Victoria, Australia.
  • Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.
  • Department of Neurology, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Australian Women with Epilepsy Ltd, Bruswick East, Victoria, Australia.

ORCID-Profile: Neha Kaul, Lucy Vivash, Susanna Chen, Lillian King, Leonid Churilov, Zhibin Chen, John-Paul Nicolo, Zanfina Ademi, Gopisankar Mohanannair Geethadevi, Efstratios Skafidas, Terence J O'Brien, Patrick Kwan

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Kaul, N., Vivash, L., Chen, S., King, L., Johns, H., Churilov, L., Chen, Z., Nicolo, J. P., Heaven, D., Meredith, E., Ervine, R., Todd, L., Zappa, B., Ademi, Z., Geethadevi, G. M., Erlichster, M., Skafidas, E., O'Brien, T. J., & Kwan, P. (2026). A randomized controlled trial of a multimodality digital health intervention to aid the delivery of the modified ketogenic diet therapy for epilepsy: The Keto eCoach trial protocol. Epilepsia Open. https://doi.org/10.1002/epi4.70345

Vancouver

Kaul N, Vivash L, Chen S, King L, Johns H, Churilov L, et al. A randomized controlled trial of a multimodality digital health intervention to aid the delivery of the modified ketogenic diet therapy for epilepsy: The Keto eCoach trial protocol. Epilepsia Open. 2026. doi:10.1002/epi4.70345

BibTeX
@article{Kaul2026,
  author = {Kaul, Neha and Vivash, Lucy and Chen, Susanna and King, Lillian and Johns, Hannah and Churilov, Leonid and Chen, Zhibin and Nicolo, John-Paul and Heaven, Danielle and Meredith, Ella and Ervine, Ryan and Todd, Lisa and Zappa, Bernadette and Ademi, Zanfina and Geethadevi, Gopisankar Mohanannair and Erlichster, Michael and Skafidas, Efstratios and O'Brien, Terence J and Kwan, Patrick},
  title = {A randomized controlled trial of a multimodality digital health intervention to aid the delivery of the modified ketogenic diet therapy for epilepsy: The Keto eCoach trial protocol},
  journal = {Epilepsia Open},
  year = {2026},
  doi = {10.1002/epi4.70345}
}
Kostenlos starten →